Role of thioredoxin-1 in apoptosis induction by α-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells

FEBS Letters

Volumn 580, Issue 11, 2006, Pages 2671-2676

  Freeman, Ruth E ^a   Neuzil, Jiri ^a,b  

^a Heart Foundation Research Centre   (Australia)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Tocopheryl succinate; Apoptosis; Malignant mesothelioma; Thioredoxin 1; TNF related apoptosis inducing ligand

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; THIOREDOXIN; THIOREDOXIN 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL FUNCTION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MESOTHELIOMA; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; HUMANS; MEMBRANE GLYCOPROTEINS; MESOTHELIOMA; RNA, SMALL INTERFERING; THIOREDOXIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN E;

TOSCANA VIRUS;

EID: 33646188728     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.04.019     Document Type: Article

References (38)

1. Godleski J.J. Role of asbestos in etiology of malignant pleural mesothelioma. Thorac. Surg. Clin. 14 (2004) 479-487
2. Vogelzang N.J., Porta C., and Mutti L. New agents in the management of advanced mesothelioma. Semin. Oncol. 32 (2005) 336-350
3. Leigh J., and Driscoll T. Malignant mesothelioma in Australia, 1945-2002. Int. J. Occup. Environ. Health 9 (2003) 206-217
4. Tomek S., Emri S., Krejcy K., and Manegold C. Chemotherapy for malignant pleural mesothelioma: past results and recent development. Br. J. Cancer 88 (2003) 167-174
5. Gazdar A.F., Butel J.S., and Carbone M. SV40 and human tumours: myth, association or causality?. Nat. Rev. Cancer 2 (2002) 957-964
6. Fennell DA., and Rudd R.M. Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. Lancet Oncol. 5 (2004) 354-362
7. Narasimhan S.R., Yang L., Gerwin B.I., and Broaddus V.C. Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax. Am. J. Physiol. 275 (1998) L165-L171
8. Carbone M., Rizzo P., Grimley P.M., Procopio A., Mew D.J., Shridhar V., de Bartolomeis A., Esposito V., Giuliano M.T., Levine A.S., Giordano A., and Pass H.I. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat. Med. 3 (1997) 908-912
9. Cacciotti P., Barbone D., Porta C., Altomare D.A., Mutti L., and Gaudino G. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. Cancer Res. 65 (2005) 5256-5262
10. Soini Y., Kinnula V., Kaarteenaho-Wiik R., Kurttila E., Linnainmaa K., and Paakko P. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-x, and bax in malignant mesothelioma. Clin. Cancer Res. 5 (1999) 3508-3515
11. Neuzil J., Tomasetti M., Mellick A.S., Alleva R., Salvatore B.A., Birringer B., and Fariss M.W. Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effect. Curr. Cancer Drug Targets 4 (2004) 267-284
12. Neuzil J., Weber T., Gellert N., and Weber C. Selective cancer cell killing by α-tocopheryl succinate. Br. J. Cancer 84 (2001) 87-89
13. Neuzil J., Weber T., Schroeder A., Lu M., Ostermann G., Gellert N., Mayne G.C., Olejnicka B., Negre-Salvayre A., Sticha M., Coffey R.J., and Weber C. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathway and structural requirements. FASEB J. 15 (2001) 403-415
14. Weber T., Lu M., Andera L., Lahm H., Gellert N., Fariss M.W., Korinek V., Sattler W., Ucker D.S., Terman A., Schröder A., Erl W., Brunk U., Coffey R.J., Weber C., and Neuzil J. Vitamin E succinate is a potent novel anti-neoplastic agent with high tumor selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin. Cancer Res. 8 (2002) 863-869
15. Swettenham E., Witting P.K., Salvatore B.A., and Neuzil J. α-Tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system. J. Neurochem. 94 (2005) 1448-1456
16. Tomasetti M., Gellert N., Procopio A., and Neuzil J. A vitamin E analogue suppresses malignant mesothelioma in a pre-clinical model: a prototype of a future drug against a fatal neoplastic disease. Int. J. Cancer 109 (2004) 641-642
17. Stapelberg M., Gellert N., Swettenham E., Tomasetti M., Witting P.K., Procopio A., and Neuzil J. α-Tocopheryl succinate inhibits malignant mesothelioma by disruption of the FGF autocrine signaling loop: mechanism and the role of oxidative stress. J. Biol. Chem. 280 (2005) 25369-25376
18. Weber T., Dalen H., Andera L., Nègre-Savayre A., Augè N., Sticha M., Loret A., Terman A., Witting P., Higuchi M., Plasilova M., Zivny J., Gallert N., Weber C., and Neuzil J. Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with anti-neoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 42 (2003) 4277-4291
19. Yamamoto S., Tamai H., Ishisaka R., Kanno T., Arita K., Kobuchi H., and Utsumi K. Mechanism of α-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells. Free Radic. Res. 33 (2000) 407-418
20. Yu W., Sanders B.G., and Kline K. RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 63 (2003) 2483-2491
21. Tomasetti M., Rippo M.R., Alleva R., Moretti S., Andera L., Neuzil J., and Procopio A. α-Tocopheryl succinate and TRAIL selectively synergise in apoptosis induction in human malignant mesothelioma cells. Br. J. Cancer 90 (2004) 1644-1653
22. Liu W., Bodle E., Chen J.Y., Gao M., Rosen G.D., and Broaddus V.C. Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines. Am. J. Respir. Cell Mol. Biol. 25 (2001) 111-118
23. Kang Y.H., et al. Role of reactive oxygen species in the induction of apoptosis by α-tocopheryl succinate. Int. J. Cancer 112 (2004) 385-392
24. Wang X.F., Witting P.K., Salvatore B.A., and Neuzil J. α-Tocopheryl succinate induces apoptosis in HER2/erbB2-overexpressing breast cancer cells by signalling via the mitochondrial pathway. Biochem. Biophys. Res. Commun. 326 (2005) 282-289
25. Alleva R., Tomasetti M., Andera L., Gellert N., Borghi B., Weber C., Murphy M.P., and Neuzil J. Coenzyme Q blocks biochemical but not receptor-mediated apoptosis by increasing mitochondrial antioxidant protection. FEBS Lett. 503 (2001) 46-50
26. Haendeler J., Tischler V., Hoffmann J., Zeiher A.M., and Dimmeler S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett. 577 (2004) 427-433
27. Powis G., Mustacich D., and Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29 (2000) 312-322
28. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606
29. Pass H.I., Stevens E.J., Oie H., Tsokos M.G., Abati A.D., Fetsch P.A., Mew D.J., Pogribniak H.W., and Matthews W.J. Characteristics of nine newly derived mesothelioma cell line. Ann. Thorac. Surg. 59 (1995) 835-844
30. Plasilova M., Zivny J., Jelinek J., Neuwirtova R., Cermak J., Necas E., Andera L., and Stopka T. TRAIL (Apo 2L) suppressed growth of primary human leukaemia and myelodysplasia progenitors. Leukemia 16 (2002) 67-73
31. Boersma A.W.M., Nooter K., Oostrum R.G., and Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 24 (1996) 123-130
32. Di Trapani G., Perkins A., and Clarke F. Production and secretion of thioredoxin from transformed human trophoblast cells. Mol. Hum. Reprod. 4 (1998) 369-375
33. Arner E.S., Zhong L., and Holmgren A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol. 300 (1999) 226-239
34. Ostareck D.H., Ostareck-Lederer A., Wilm M., Thiele B.J., Mann M., and Hentze M.W. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89 (1997) 597-606
35. French L.E., and Tschopp J. The TRAIL to selective tumor death. Nat. Med. 5 (1999) 146-147
36. Kahlos K., Soini Y., Saily M., Koistinen P., Kakko S., Paakko P., Holmgren A., and Kinnula V.L. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma. Int. J. Cancer 95 (2001) 198-204
37. Burke-Gaffney A., Callister M.E., and Nakamura H. Thioredoxin: friend or foe in human disease?. Trends Pharmacol. Sci. 26 (2005) 398-404
38. Kinnula V.L., Paakko P., and Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett. 569 (2004) 1-6